Citation Impact
Citing Papers
STIM1, an essential and conserved component of store-operated Ca2 + channel function
2005 Standout
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche
2007
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
2019
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand
2002 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
1998 Standout
The extracellular matrix of the hematopoietic microenvironment
1995
Growth inhibition of cervical cancer cells by the human retinoic acid receptor β gene
2000
Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
2010
De novo protein design. I. in search of stability and specificity
1999 StandoutNobel
Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia—retrospective study and review of literature
2004
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
1996
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Interleukin-4 and lnterleukin-13: Their Similarities and Discrepancies
1998
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
2009
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Chemotherapy and the war on cancer
2005 Standout
Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma
2009
Philadelphia Chromosome–Positive Acute Myeloid Leukemia
2007
Prevention of Venous Thromboembolism
2004 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia
1995
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Growth factors in acute myeloid leukaemia
2001
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
1996 Standout
Gastric cancer
2020 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
INTERACTION OF TUMOR AND HOST CELLS WITH ADHESION AND EXTRACELLULAR MATRIX MOLECULES IN THE DEVELOPMENT OF MULTIPLE MYELOMA
1997
Interleukin 10 inhibits cytokine production of human AML cells
1996
Sex differences in immune responses
2016 Standout
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
Phagocytosis: measurement by flow cytometry
2000
Mechanisms of Bone Metastasis
2004 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
2005
A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia
1995
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater
2007
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
2007
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
2005 Standout
Updates on Management of Gastric Cancer
2019
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
Unprecedented intramolecular cyclization of pyridinium to pyrido[1,2-a]benzimidazole: a novel chemodosimeter for fluoride ions
2011
Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women
2006
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Identification of stromal cell products that interact with pre-B cells.
1996
Bendamustine: Rebirth of an Old Drug
2009
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022
1997
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
1996
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
GM-CSF in a Double-Blind Randomized Placebo-Controlled Trial in Therapy of Adult Patients with De Novo Acute Myeloid Leukemia
1994
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors
2000 Standout
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion
1994
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial
2001
Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the Metalloproteinase gelatinase B (MMP-9)
1999
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
1997
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
Unique anti-activator protein-1 activity of retinoic acid receptor beta.
2000
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
A randomized placebo-controlled phase III study of granulocyte- macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
1995
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Recent Advances in the Liquid-Phase Syntheses of Inorganic Nanoparticles
2004 Standout
Hematopoietic growth factors and their receptors in acute leukemia
1993
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
2015
Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein–Barr virus infection and high‐ and low‐microsatellite instability
2019
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
1995 StandoutScience
Protective Coating of Superparamagnetic Iron Oxide Nanoparticles
2003
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study
2008
Cytokine Receptors and Signal Transduction
1992
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
IL-1β Scavenging by the Type II IL-1 Decoy Receptor in Human Neutrophils
2003
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Immunotoxins for targeted cancer therapy
1998
Reference Ranges for Lymphocyte Subsets among Healthy Hong Kong Chinese Adults by Single-Platform Flow Cytometry
2013
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
1998 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
1993
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Works of Michael Koenigsmann being referenced
Immunomagnetic Selection of CD34+ Cells from Fresh Peripheral Blood Mononuclear Cell Preparations Using Two Different Separation Techniques
1995
Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults—A monocentric German study
2005
Increased risk of venous thromboembolism in patients with acute leukaemia
2006
Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy—A case report on the basis of a clinical phase II trial
1990
Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivo
1992
Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma—a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO)
2004
Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis
2005
Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells
1997
High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial
2004
Myeloid and erythroid progenitor cells from normal bone marrow adhere to collagen type I
1992
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
2017
Recombinant human GM-CSF following chemotherapy in high-risk AML.
1990
Internalization of the granulocyte-macrophage colony-stimulating factor receptor is not required for induction of protein tyrosine phosphorylation in human myeloid cells
1991
Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib.
2004
Reversible leukaemic regrowth under GM-CSF treatment after chemotherapy for AML
1991
Differentiation-associated expression of two functionally distinct classes of granulocyte-macrophage colony-stimulating factor receptors by human myeloid cells.
1990
Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
2017
Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early death.
1988
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse
1991
Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo
1993
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse
1991